NeuroBo Pharmaceuticals Statistics

Total Valuation

NRBO has a market cap or net worth of $25.57 million. The enterprise value is $9.77 million.

Market Cap	25.57M
Enterprise Value	9.77M

Important Dates

The next estimated earnings date is Wednesday, August 7, 2024, after market close.

Earnings Date	Aug 7, 2024
Ex-Dividend Date	n/a

Share Statistics

NRBO has 5.67 million shares outstanding. The number of shares has increased by 0.60% in one year.

Shares Outstanding	5.67M
Shares Change (YoY)	+0.60%
Shares Change (QoQ)	-0.02%
Owned by Insiders (%)	67.86%
Owned by Institutions (%)	9.59%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.54
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.46, with a Debt / Equity ratio of 0.02.

Current Ratio	2.46
Quick Ratio	n/a
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -90.20% and return on invested capital (ROIC) is -197.28%.

Return on Equity (ROE)	-90.20%
Return on Assets (ROA)	-69.50%
Return on Capital (ROIC)	-197.28%
Revenue Per Employee	n/a
Profits Per Employee	-$2.07M
Employee Count	8
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +10.43% in the last 52 weeks. The beta is -0.29, so NRBO's price volatility has been lower than the market average.

Beta (5Y)	-0.29
52-Week Price Change	+10.43%
50-Day Moving Average	4.29
200-Day Moving Average	4.03
Relative Strength Index (RSI)	50.63
Average Volume (20 Days)	107,877

Short Selling Information

The latest short interest is 92,600, so 1.63% of the outstanding shares have been sold short.

Short Interest	92,600
Short Previous Month	58,538
Short % of Shares Out	1.63%
Short % of Float	n/a
Short Ratio (days to cover)	1.20

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-20.25M
Pretax Income	-16.58M
Net Income	-16.58M
EBITDA	-16.57M
EBIT	-16.58M
Earnings Per Share (EPS)	-$3.22

Full Income Statement

Balance Sheet

The company has $15.99 million in cash and $187,000 in debt, giving a net cash position of $15.80 million or $2.79 per share.

Cash & Cash Equivalents	15.99M
Total Debt	187,000
Net Cash	15.80M
Net Cash Per Share	$2.79
Equity (Book Value)	10.08M
Book Value Per Share	1.78
Working Capital	9.94M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$14.69 million and capital expenditures -$51,000, giving a free cash flow of -$14.75 million.

Operating Cash Flow	-14.69M
Capital Expenditures	-51,000
Free Cash Flow	-14.75M
FCF Per Share	-$2.90

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NRBO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.60%
Shareholder Yield	-0.60%
Earnings Yield	-64.84%
FCF Yield	-57.67%

Analyst Forecast

The average price target for NRBO is $10.00, which is 121.73% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	121.73%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on December 21, 2023. It was a reverse split with a ratio of 1:8.

Last Split Date	Dec 21, 2023
Split Type	Reverse
Split Ratio	1:8

Scores

Altman Z-Score	n/a
Piotroski F-Score	1